Nykode Therapeutics
Mindre end 1K følgere
NYKD
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Nykode Therapeutics operates in biotechnology. The company is today specialized in the research and development of immunological therapies and vaccines. The solutions are mainly used for the treatment of patients with cancer and other serious health conditions that require long-term treatment. The main business of Nykode Therapeutics is found in the European market.
Læs mereMarkedsværdi
-
Aktieomsætning
-
Omsætning
98,39 mio.
EBIT %
-556,8 %
P/E
-
Udbytteafkast, %
-
Finanskalender
14.5
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '25
20.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Nykode Therapeutics - Quarterly report Q4 2024
Nykode Therapeutics - invitation to Q4 2024 financial results presentation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools